Qvar redihaler 80 MCG 10.6GM
Ended Awarded
- Contract number
- SPE2DB26FATZZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,812
Award facts
- Contract value 100% obligated
- $1,811.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $1,811.51 to DMS Pharmaceutical Group Inc. for QVAR Redihaler 80 mcg inhalers (10.6 gm units) on October 29, 2025, with completion scheduled for October 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded this firm fixed-price delivery order without set-aside designation. The order represents one of numerous delivery orders issued to the contractor by DLA's Medical Supply Chain division during October 2025, reflecting the agency's ongoing demand for pharmaceutical products to support Department of Defense healthcare operations.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion enterprise-wide pharmaceutical acquisition strategy. The underlying IDC, designated SPE2DR and valued at $499.999 billion, was awarded November 13, 2025, and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group supplies a comprehensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to military healthcare facilities worldwide, positioning the company as a critical supplier within the federal pharmaceutical supply chain for military medical systems.
Quick answers
Who was awarded contract SPE2DB26FATZZ?
SPE2DB26FATZZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FATZZ worth?
The government has obligated $1,812 on SPE2DB26FATZZ.
Is contract SPE2DB26FATZZ an order under another contract?
Yes. SPE2DB26FATZZ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZZ competed?
The extent of competition for SPE2DB26FATZZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award